You just read:

Lilly and Sigilon Therapeutics Announce Strategic Collaboration to Develop Encapsulated Cell Therapies for the Treatment of Type 1 Diabetes

News provided by

Eli Lilly and Company

Apr 04, 2018, 07:00 ET